Abstract
Hypoxia-ischemia (HI) occurs in 1-6/1000 live full-term births (Shankaran, 2009). Of those affected, 15-20% will die in the postnatal period, and 25% of survivors will be left with long-term neurological disabilities (Gunn, 2000; Vannucci, 1997; Fatemi, 2009). It has become increasingly clear that peripheral immune cells infiltrate the brain parenchyma as part of the physiological response to tissue damage after HI injury. The interplay between infiltrating immune cells and brain resident cells during the inflammatory response is however dynamic and complex; in that neuro-immune crosstalk, by way of specific molecular mediators, is responsible for both neurodestructive as well as neuroprotective outcomes. Herein, we tested the hypothesis that COX-2 mediates mechanisms of brain injury and that G-CSF exerts structural and functional protection after neonatal HI.
To mimic the clinical features of HI brain injury, neonatal rat pups were subjected to unilateral carotid artery ligation followed by 2 hours of hypoxia (8% O2 at 37°C). We used a gain and loss of function approach (pharmacological activation or inhibition, respectively) for COX-2, a neutralizing antibody for lL-15, and a gene silencer for natural killer cells in both splenectomized and non-splenectomized rats to verify the role of COX-2 in splenic immune cell responses following HI. We found that elevations in COX-2 expression by immune cells promoted IL-15 expression in astrocytes and infiltration of inflammatory cells; additionally, down-regulated the pro-survival protein, PI3K, resulting in caspase-3 mediated neuronal death. Additionally, we investigated the efficacy of G-CSF on long-term Hl-induced morphological and functional outcomes using two different dosing regimens; and found the neurotrophic factor to significantly improve behavioral and neuropathological recovery.
These results provide insight into the mechanistic basis of mflammation and indentify key components of the neuroinflammatory response after HI. Thus, we propose that COX-2 inhibition or G-CSF administration during the acute phase of injury are novel therapeutic modalities that target detrimental and beneficial mechanisms of neuroinflammation, respectively, and may offer a safe and effective option with longterm benefits for the Hl-injured infant.
LLU Discipline
Anatomy
Department
Anatomy
School
Graduate Studies
First Advisor
John H. Zhang
Second Advisor
Stephen Ashwal
Third Advisor
Michael A. Kirby
Fourth Advisor
Pedro B. Nava
Fifth Advisor
Jiping Tang
Degree Name
Doctor of Philosophy (PhD)
Degree Level
Ph.D.
Year Degree Awarded
2010
Date (Title Page)
6-2010
Language
English
Library of Congress/MESH Subject Headings
Hypoxia-Ischemia, Brain -- physiopathology; Brain Injuries -- etiology; Brain Infarction -- drug therapy; Inflammation -- pathology; Inflammation Mediators -- therapeutic use; Neuroprotective Agents -- pharmacology; Neurologic Examination -- methods; Blotting; Western; Animals; Newborn Rats; Sprague-Dawley
Type
Dissertation
Page Count
xiv; 178
Digital Format
Digital Publisher
Loma Linda University Libraries
Copyright
Author
Usage Rights
This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights.
Recommended Citation
Fathali, Nancy, "Therapeutic Modalities Targeting Neuroinflammation After Neonatal Hypoxia-Ischemia" (2010). Loma Linda University Electronic Theses, Dissertations & Projects. 1181.
https://scholarsrepository.llu.edu/etd/1181
Collection
Loma Linda University Electronic Theses and Dissertations
Collection Website
http://scholarsrepository.llu.edu/etd/
Repository
Loma Linda University. Del E. Webb Memorial Library. University Archives